Assertio Holdings, Inc. (ASRT)
18.13
+0.12
(+0.67%)
USD |
NASDAQ |
Apr 20, 09:50
Assertio Holdings SG&A Expense (Quarterly) : 9.58M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Castle Biosciences, Inc. | 56.73M |
| ANI Pharmaceuticals, Inc. | 82.79M |
| Alkermes Plc | 187.20M |
| Catalyst Pharmaceuticals, Inc. | 48.23M |
| Aura Biosciences, Inc. | 5.34M |